Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 11

791P - Development and validation of nomograms to predict survival in patients with high-grade serous ovarian cancer

Date

21 Oct 2023

Session

Poster session 11

Topics

Tumour Site

Ovarian Cancer

Presenters

Xiaolian Peng

Citation

Annals of Oncology (2023) 34 (suppl_2): S507-S542. 10.1016/S0923-7534(23)01937-3

Authors

X. Peng1, J. Liu2

Author affiliations

  • 1 Department Of Obstetrics And Gynecology, Linxiang City People's Hospital of Hunan Province, China., 414300 - Linxiang City/CN
  • 2 Department Of Vascular And Endovascular Surgery, Chinese PLA General Hospital, Beijing, China., 100000 - Beijing City/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 791P

Background

The current American Joint Committee on Cancer TNM and FIGO systems are without sufficient details encompassing the variety of ovarian cancer. To develop and validate nomograms for overall survival (OS) and cancer-specific survival (CSS) in patients with high-grade serous ovarian cancer (HGSOC).

Methods

The collection of data from California, Connecticut, Detroit, Georgia, Hawaii Iowa was formed as the development cohort. A cohort of data from Kentucky, Louisiana, New Jersey, New Mexico, Seattle, and Utah formed the external validation cohorts. We developed the nomograms using the Cox prediction model. We applied five-method comparisons to screen the best model for both nomograms, and the nomogram models underwent successful independent external validations to support their reliability. We assessed nomogram model performance by examining overall accuracy (Brier score), calibration (calibration plots and Hosmer–Lemeshow calibration test), and discrimination (Harrell C index).

Results

The development cohorts included 2465 patients which were split into two parts (7:3) for the development (n=1726) and internal validation (n=739) for the model, and the 5-year overall survival was 18·6% (458/2465). The OS nomogram showed that Scope Reg LN Sur (0-100), AJCC_N (0-89.37), Systemic Sur Seq (0-74.25), the year of diagnosis (0-69.15), and Surg Prim Site(0-51.52) shared the larger contribution to prognosis. Followed by AJCC_ M (0–48.42) and age (0–45.31). The C index of 5-year OS and CSS nomograms was 0.715 (95% CI 0.688–0.741) and 0.719 (0.693–0.745) in the development cohort, 0.695 (0.646–0.744) and 0.702 (0.653–0.750) in the internal validation cohorts. The external validation cohorts included 961 patients, were 0.684 (0.644–0.724) and 0.687 (0.648–0.727). The nomograms performed well according to overall accuracy, discrimination, and calibration when they were applied to the validation cohorts.

Conclusions

Our nomograms are credible methods that can be used to predict OS and CSS in patients with HGSOC. They should be offered to clinicians to assess patient prognosis, make prognosis-based decisions and be conducive to stratifying patients in clinical trials or population-based analyses, and inform patients clinically.

Clinical trial identification

Editorial acknowledgement

We gratefully thank the SEER database for providing data support. we also express sincere gratitude to Steve for guiding us on how to handle the data of alive or dead of other causes to perform Cause-specific survival analysis. At the same time, we thank the Free Statistics team for providing technical guidance and valuable tools for data analysis and visualization.

Legal entity responsible for the study

J. Liu.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.